Press & News
People are different and so is their cancer, patients should be treated individually.
New The power of precision, For Every Oncologist, Today
With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.
The latest news around the IndiTreat® clinical trial in colorectal cancer patients that met its primary endpoint.
2cureX Newsletter March 2nd 2021
2cureX reaches primary endpoint (BioStock article)
IndiTreat® selected to prestigious multinational ovarian cancer project (Biostock article)
2cureX supports World Cancer Day February 4th 2021
RedEye interview with CEO Fernando Andreu and CSO Ole Thastrup
Ole Thastrup presents at the Virtual RedEye Fight Cancer 2021 meeting January 21st
2cureX appoints new CEO (BioStock)
Key achievements in 2020 – an IndiTreat® Launch year
Get notified on mail, when news or press release is posted on our website